股票行情快报：英科医疗（300677）11月18日主力资金净卖出2485.58万元

Core Viewpoint - The stock of Yingke Medical (300677) has shown a decline in price and mixed capital flow, indicating potential challenges in market sentiment and performance [1][2]. Financial Performance - As of November 18, 2025, Yingke Medical's stock closed at 37.39 yuan, down 0.98%, with a trading volume of 74,200 hands and a turnover of 279 million yuan [1]. - In the third quarter of 2025, the company reported a main revenue of 25.11 billion yuan, a year-on-year decrease of 2.9%, while the net profit attributable to shareholders was 2.14 billion yuan, an increase of 113.04% [3]. - For the first three quarters of 2025, the total revenue was 74.25 billion yuan, up 4.6% year-on-year, and the net profit was 9.24 billion yuan, up 34.47% year-on-year [3]. Capital Flow Analysis - On November 18, 2025, the net outflow of main funds was 24.86 million yuan, accounting for 8.91% of the total turnover, while retail investors saw a net inflow of 39.62 million yuan, representing 14.2% of the total turnover [1][2]. - Over the past five days, the stock has experienced significant fluctuations in capital flow, with notable net outflows from main and speculative funds on several days [2]. Industry Comparison - Yingke Medical's total market capitalization is 24.483 billion yuan, significantly higher than the industry average of 11.405 billion yuan, ranking 8th in the industry [3]. - The company's net profit margin stands at 12.82%, which is above the industry average of 9.57%, ranking 53rd in the industry [3]. - The gross profit margin of Yingke Medical is 23.7%, which is considerably lower than the industry average of 51.22%, ranking 115th in the industry [3]. Analyst Ratings - In the last 90 days, 8 institutions have provided ratings for Yingke Medical, with 7 buy ratings and 1 hold rating, indicating a generally positive outlook from analysts [4].